Global X Genomics & Biotechnology UCITS ETF - USD Stock

ETF

GNOG

IE00BM8R0N95

Market Closed - London S.E. 11:35:19 2026-07-17 EDT 5-day change 1st Jan Change
9.741 USD -1.69% Intraday chart for Global X Genomics & Biotechnology UCITS ETF - USD -2.90% +19.33%
Current month-3.79%
1 month+5.09%

Investment objective

The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the Index).
Off-Hours Price
Change
YTD change
Weight
61.82USD-2.11%+109.63%7.56%
314.41USD+2.01%+6.67%6.29%
74.30USD+4.10%+11.91%5.7%
155.87USD+0.56%+52.60%4.9%
186.65USD-1.89%+42.31%4.84%
59.59USD-0.68%+0.27%4.27%
485.65USD-0.08%+7.12%4.15%
271.39USD+0.58%+18.46%4.05%
91.48USD-0.09%-3.91%3.8%
In partnership with
TrackInsight
Date Price Change Volume
26-07-17 US$9.741 -1.69% 5,045
26-07-16 US$9.908 -0.74% 2,127
26-07-15 US$9.982 +0.42% 1,471
26-07-14 US$9.940 -0.45% 687
26-07-13 US$9.984 -0.48% 9,395

Delayed Quote London S.E.

Last update July 17, 2026 at 11:35 am

Description

IE00BM8R0N95
Total Expense Ratio 0.50%
Asset Class Stocks
Currency
Provider
Underlying Solactive Genomics v2 Index - USD
Autres ETFs

Features and characteristics

Dividend Policy Capitalisation
Replication Method Physique
Jurisdiction
Fund Structure
Date of creation
2021-11-03

Distribution

Retail investor

AuM evolution - 2026-02-26

AuM (USD) 22.03M
AuM 1M 20.49M
AuM 3 months 19.76M
AuM 6 months 10.96M
AuM 12 months 10.16M
  1. Stock Market
  2. ETF
  3. GNOG ETF